福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300194 福安药业

已收盘 09-22 15:00:00

{"stockData":{"symbol":"300194","market":"SZ","secType":"STK","nameCN":"福安药业","latestPrice":3.99,"timestamp":1790060586000,"preClose":3.99,"halted":0,"volume":21787684,"delay":0,"changeRate":0,"floatShares":968000000,"shares":1190000000,"eps":0.0502,"marketStatus":"已收盘","change":0,"latestTime":"09-22 15:00:00","open":3.97,"high":4.03,"low":3.92,"amount":86708900,"amplitude":0.0276,"askPrice":3.99,"askSize":19,"bidPrice":3.98,"bidSize":5650,"shortable":0,"etf":0,"ttmEps":0.0502,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790127000000},"marketStatusCode":5,"adr":0,"adjPreClose":3.99,"symbolType":"stock","openAndCloseTimeList":[[1790040600000,1790047800000],[1790053200000,1790060400000]],"highLimit":4.39,"lowLimit":3.59,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1189712382,"isCdr":false,"pbRate":1.08,"roa":"--","peRate":79.482072,"roe":"2.18%","epsLYR":0.06,"committee":-0.269283,"marketValue":4747000000,"turnoverRate":0.0225,"status":2,"floatMarketCap":3864000000},"requestUrl":"/m/hq/s/300194/wiki","defaultTab":"wiki","newsList":[{"id":"2667364587","title":"福安药业(300194)9月10日股东户数3.7万户，较上期减少3.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667364587","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667364587?lang=zh_cn&edition=full","pubTime":"2026-09-15 17:39","pubTimestamp":1789465195,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福安药业披露，截至2026年9月10日公司股东户数为3.7万户，较8月10日减少1294.0户，减幅为3.38%。在化学制药行业个股中，福安药业股东户数高于行业平均水平，截至9月10日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年8月10日至2026年9月10日，福安药业区间跌幅为0.26%，在此期间股东户数减少1294.0户，减幅为3.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500028189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0132","300194","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667163856","title":"股市必读：福安药业新发布《关于子公司收到药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667163856","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667163856?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:15","pubTimestamp":1789326913,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，福安药业报收于3.81元，下跌1.8%，换手率1.22%，成交量11.81万手，成交额4492.9万元。当日关注点交易信息汇总：9月11日主力资金净流出316.02万元，占总成交额7.03%。公司公告汇总：全资子公司庆余堂收到注射用赖氨匹林药品注册证书，注册分类为化药3类。截至目前，共有11家企业通过或视同通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0132","300194","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666308542","title":"福安药业：子公司收到注射用赖氨匹林药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2666308542","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666308542?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:03","pubTimestamp":1789113828,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0060","BK0132","BK0239","BK0028","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035322","title":"股市必读：福安药业新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035322","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662035322?lang=zh_cn&edition=full","pubTime":"2026-08-28 05:03","pubTimestamp":1787864600,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年半年度报告摘要显示，营业收入8.39亿元，同比下降8.82%；归母净利润9577.48万元，同比下降15.33%；经营活动现金流量净额1.84亿元，同比上升200.84%。公司公告汇总：第六届董事会第七次会议审议通过《2026年半年度报告》及其摘要，全体董事签署书面确认意见。公司公告汇总：2026年半年度非经营性资金占用及其他关联资金往来情况显示，对子公司其他应收款期末余额1.92亿元，系借款形成；控股股东及实际控制人无非经营性资金占用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0028","BK0060","BK0239","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662770469","title":"福安药业最新公告：子公司硫酸艾沙康唑原料药获上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662770469","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662770469?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:31","pubTimestamp":1787830296,"startTime":"0","endTime":"0","summary":"福安药业(300194.SZ)公告称，公司全资子公司福安药业集团重庆博圣制药有限公司近日收到国家药品监督管理局签发的化学原料药上市申请批准通知书，涉及原料药硫酸艾沙康唑。该药物主要用于治疗侵袭性曲霉病和侵袭性毛霉病，获批后可在国内上市制剂中使用，将进一步丰富子公司产品线。但受GMP合规性检查、国家政策及市场环境等因素影响，生产销售时间及具体销售情况存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700046247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0239","BK0028","BK0060","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662971013","title":"福安药业（300194）披露2026年半年度报告，8月26日股价上涨0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662971013","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662971013?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:24","pubTimestamp":1787754257,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，福安药业报收于3.99元，较前一交易日上涨0.25%，最新总市值为47.47亿元。该股当日开盘3.95元，最高4.06元，最低3.95元，成交额达1.01亿元，换手率为2.61%。近日，福安药业（集团）股份有限公司披露《2026年半年度报告》。公告显示，本报告期营业收入为839,297,466.77元，较上年同期下降8.82%；归属于上市公司股东的净利润为95,774,808.12元，同比下降15.33%；扣除非经常性损益后的净利润为86,436,552.47元，同比下降16.93%。经营活动产生的现金流量净额为183,979,476.81元，同比上升200.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600053008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0028","BK0060","BK0239","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662279026","title":"图解福安药业中报：第二季度单季净利润同比下降7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662279026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662279026?lang=zh_cn&edition=full","pubTime":"2026-08-26 18:38","pubTimestamp":1787740735,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业2026年中报显示，上半年度公司主营收入8.39亿元，同比下降8.82%；归母净利润9577.48万元，同比下降15.33%；扣非净利润8643.66万元，同比下降16.93%；其中2026年第二季度，公司单季度主营收入4.32亿元，同比下降4.64%；单季度归母净利润4085.85万元，同比下降7.29%；单季度扣非净利润3778.69万元，同比下降1.51%；负债率21.7%，投资收益2037.02万元，财务费用491.78万元，毛利率39.59%。财报数据概要请见下图:本文数据来源于福安药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600042273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662928777","title":"福安药业(300194)8月10日股东户数3.83万户，较上期增加0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662928777","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662928777?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:45","pubTimestamp":1787737556,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福安药业披露，截至2026年8月10日公司股东户数为3.83万户，较7月20日增加337.0户，增幅为0.89%。在化学制药行业个股中，福安药业股东户数高于行业平均水平，截至8月10日，化学制药行业平均股东户数为3.68万户。从股价来看，2026年7月20日至2026年8月10日，福安药业区间涨幅为3.46%，在此期间股东户数增加337.0户，增幅为0.89%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600040118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0132","BK0028","BK0239","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658739069","title":"福安药业(300194)8月10日股东户数3.83万户，较上期增加0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658739069","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658739069?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:26","pubTimestamp":1786526803,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福安药业披露，截至2026年8月10日公司股东户数为3.83万户，较7月20日增加337.0户，增幅为0.89%。在化学制药行业个股中，福安药业股东户数高于行业平均水平，截至8月10日，化学制药行业平均股东户数为3.6万户。从股价来看，2026年7月20日至2026年8月10日，福安药业区间涨幅为3.46%，在此期间股东户数增加337.0户，增幅为0.89%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200029508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0028","300194","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658866909","title":"福安药业：努力做好投资者关系管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2658866909","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658866909?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:45","pubTimestamp":1786347911,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业08月10日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000015378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0060","BK0028","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658262670","title":"股市必读：福安药业（300194）8月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2658262670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658262670?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:42","pubTimestamp":1786297331,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，福安药业报收于3.82元，上涨3.52%，换手率3.4%，成交量32.89万手，成交额1.24亿元。董秘最新回复投资者： 公司业绩，股价长期走弱，投资者损失较大，多项合理化建议均被答复暂无计划。公司有哪些维护中小股东权益的实际举措，谢绝套话。当日关注点交易信息汇总：8月7日主力资金净流入838.61万元，占总成交额6.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0060","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657356874","title":"股市必读：福安药业（300194）8月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657356874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657356874?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:21","pubTimestamp":1785864069,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，福安药业报收于3.75元，上涨0.0%，换手率2.0%，成交量19.39万手，成交额7312.05万元。董秘最新回复投资者： 董秘您好，市场上如长缆科技等多家上市公司，使用“维护公司价值及股东权益”回购，低位回购作为库存股，后续择机处置，稳定二级市场波动。当日关注点交易信息汇总：8月4日主力资金净流出995.09万元，占总成交额13.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0028","BK0060","BK0239","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656306832","title":"股市必读：福安药业新发布《关于子公司收到药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656306832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656306832?lang=zh_cn&edition=full","pubTime":"2026-08-04 02:08","pubTimestamp":1785780494,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，福安药业报收于3.75元，上涨1.08%，换手率1.75%，成交量16.97万手，成交额6325.97万元。当日关注点交易信息汇总：8月3日主力资金净流出162.39万元，占总成交额2.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0132","300194","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656217613","title":"福安药业(300194.SZ)子公司收到注射用头孢他啶阿维巴坦纳药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2656217613","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656217613?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:28","pubTimestamp":1785745734,"startTime":"0","endTime":"0","summary":"智通财经APP讯，福安药业(300194.SZ)发布公告，公司全资子公司福安药业集团庆余堂制药有限公司于近日收到国家药品监督管理局签发的注射用头孢他啶阿维巴坦纳的药品注册证书。注射用头孢他啶阿维巴坦纳适用于治疗复杂性腹腔内感染;医院获得性肺炎和呼吸机相关性肺炎;在治疗方案选择有限的成人和自出生起儿童患者中治疗由对本品敏感的革兰阴性菌引起的感染。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"福安药业(300194.SZ)子公司收到注射用头孢他啶阿维巴坦纳药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300194","BK0239","BK0028","BK0060","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655072298","title":"股市必读：福安药业（300194）7月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655072298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655072298?lang=zh_cn&edition=full","pubTime":"2026-07-31 01:55","pubTimestamp":1785434115,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，福安药业报收于3.68元，下跌0.54%，换手率1.62%，成交量15.68万手，成交额5809.45万元。董秘最新回复投资者： 对比 2024 至 2025 年年报披露信息，公司在岗员工规模有所收缩，人均创收同步承压。公司准备采取何种方式改善人均经营效能，合理控制人员流失。当日关注点交易信息汇总：7月30日主力资金净流入373.94万元，占总成交额6.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0060","BK0132","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655821252","title":"福安药业：公司近两年来受药品集采政策影响，经营业绩承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2655821252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655821252?lang=zh_cn&edition=full","pubTime":"2026-07-30 16:27","pubTimestamp":1785400029,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业07月30日在投资者关系平台上答复投资者关心的问题。公司准备采取何种方式改善人均经营效能，合理控制人员流失。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000025627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654906436","title":"股市必读：福安药业(300194)股东户数3.79万户，较上期增加6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654906436","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654906436?lang=zh_cn&edition=full","pubTime":"2026-07-27 01:46","pubTimestamp":1785087974,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，福安药业报收于3.59元，下跌3.23%，换手率1.51%，成交量14.59万手，成交额5322.33万元。股本股东变化：截至7月20日股东户数为3.79万户，较6月18日增长6.08%，户均持股由3.33万股降至3.14万股。股本股东变化股东户数变动截至2026年7月20日公司股东户数为3.79万户，较6月18日增加2176.0户，增幅为6.08%；户均持股数量由上期的3.33万股减少至3.14万股，户均持股市值为11.79万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700000857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0060","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653351033","title":"福安药业（300194）披露子公司收到盐酸溴己新注射液药品注册证书，7月24日股价下跌3.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653351033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653351033?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:34","pubTimestamp":1784903661,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，福安药业报收于3.59元，较前一交易日下跌3.23%，最新总市值为42.71亿元。该股当日开盘3.68元，最高3.72元，最低3.59元，成交额达5322.33万元，换手率为1.51%。福安药业（集团）股份有限公司当日发布公告称，其全资子公司福安药业集团宁波天衡制药有限公司收到国家药品监督管理局签发的盐酸溴己新注射液药品注册证书，批准文号为国药准字H20265301，注册分类为化药3类，规格为2ml：4mg。截至目前，共有30家企业通过或视同通过一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0028","300194","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653712727","title":"股市必读：福安药业（300194）7月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653712727","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653712727?lang=zh_cn&edition=full","pubTime":"2026-07-24 02:08","pubTimestamp":1784830095,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘，福安药业报收于3.71元，上涨0.27%，换手率1.75%，成交量16.97万手，成交额6242.3万元。当日关注点交易信息汇总：7月23日主力资金净流出177.39万元，游资资金净流入482.67万元，散户资金净流出305.28万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400001497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0060","BK0132","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653717323","title":"福安药业：公司对未来发展保持信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2653717323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653717323?lang=zh_cn&edition=full","pubTime":"2026-07-23 15:51","pubTimestamp":1784793069,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业(300194)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问：8) 通常情况公司综合实力，行业地位会在资本市场的市值，PB等指标来体现 出来，目前公司市值、PB处于行业低位，请问公司如何定位自身行业位置？是否认为市场对公司存在定价错位？福安药业回复：您好，公司市值波动可能会受到行业周期、市场情绪、风格偏好等多方面因素的影响。尽管当前公司所在仿制药行业受政策影响较大，但公司对未来发展保持信心，将继续聚焦主业提质增效，在做好生产经营工作的同时，与投资者保持积极的交流互动。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300028285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0028","BK0060","BK0239","300194"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790120046893,"stockEarnings":[{"period":"1week","weight":0.064},{"period":"1month","weight":0.0153},{"period":"3month","weight":0.1271},{"period":"6month","weight":0.026},{"period":"1year","weight":-0.0832},{"period":"ytd","weight":-0.0874}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.012},{"period":"3month","weight":-0.0386},{"period":"6month","weight":0.0162},{"period":"1year","weight":0.0323},{"period":"ytd","weight":-0.0042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"福安药业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36980人(较上一季度减少3.38%)","perCapita":"26186股","listingDate":"2011-03-22","address":"重庆市长寿区化南一路1号","registeredCapital":"118971万元","survey":"　　福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是抗生素类、抗肿瘤类、特色专科药类。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号，在行业内具备一定的市场竞争力。","listedPrice":41.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福安药业,300194,福安药业股票,福安药业股票老虎,福安药业股票老虎国际,福安药业行情,福安药业股票行情,福安药业股价,福安药业股市,福安药业股票价格,福安药业股票交易,福安药业股票购买,福安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}